Study of interactions between organic contaminants and a new phosphated biopolymer derived from cellulose.

The extensive use of organic molecules (Rhodamine B and Amitriptyline) also has contributed to environmental pollution; adsorption is a relevant method for removal of these contaminants in aqueous media. In this context, the objective of this study was to modify the surface of cellulose (Cel) with phosphoric acid and sodium tripolyphosphate to obtain a biopolymer with incorporated phosphate groups (PCel). The modification was confirmed by X-ray dispersive energy spectroscopy, solid state nuclear magnetic resonance, X-ray diffraction, and thermal analysis. The obtained material (PCel) was used as a Rhodamine B (RhB) or Amitriptyline (AmTP) adsorbent, and the highest adsorption capacity of this material was obtained at pH 3.0 (RhB) and 7.0 (AmTP) and the equilibrium time was achieved at 65 (RhB) and 150 min (AmTP). Moreover, the pseudo-first-order model best describes the kinetics of this adsorption. The experimental adsorption isotherms were adjusted to the Langmuir model, indicating that monolayer adsorption occurred and the highest experimental adsorption capacity obtained was 47.58 (RhB) and 45.52 mg g-1 (AmTP) in PCel. The thermodynamic parameters showed that the adsorption process is exothermic and non-spontaneous, with increase of non-spontaneity with enhance of the temperature. However, PCel was efficient in removing the contaminant (RhB or AmTP) in an aqueous solution.

Hybrid Systems Based on Talc and Chitosan for Controlled Drug Release.

Inorganic matrices and biopolymers have been widely used in pharmaceutical fields. They show properties such as biocompatibility, incorporation capacity, and controlled drug release, which can become more attractive if they are combined to form hybrid materials. This work proposes the synthesis of new drug delivery systems (DDS) based on magnesium phyllosilicate (Talc) obtained by the sol-gel route method, the biopolymer chitosan (Ch), and the inorganic-organic hybrid formed between this matrix (Talc + Ch), obtained using glutaraldehyde as a crosslink agent, and to study their incorporation/release capacity of amiloride as a model drug. The systems were characterized by X-ray diffraction (XRD), Therma analysis TG/DTG, and Fourier-transform infrared spectroscopy (FTIR) that supported the DDS's formation. The hybrid showed a better drug incorporation capacity compared to the precursors, with a loading of 55.74, 49.53, and 4.71 mg g-1 for Talc + Ch, Talc, and Ch, respectively. The release assays were performed on a Hanson Research SR-8 Plus dissolver using apparatus I (basket), set to guarantee the sink conditions. The in vitro release tests showed a prolongation of the release rates of this drug for at least 4 h. This result proposes that the systems implies the slow and gradual release of the active substance, favoring the maintenance of the plasma concentration within a therapeutic window.

Understanding kinetics and thermodynamics of the interactions between amitriptyline or eosin yellow and aminosilane-modified cellulose.

A new adsorbent matrix (Cel-SiN) for the adsorption of the dye eosin yellow (EY) and the drug amitriptyline (AMI) from aqueous media has been synthesized. The Cel-SiN matrix was obtained via chemical modification of cellulose with (3-aminopropyl)trimethoxysilane. Successful modification was confirmed using Fourier transform infrared (FTIR) and 13C and 29Si solid state nuclear magnetic resonance (SSNMR) spectroscopies, thermal analysis (TG/DTG), X-ray diffraction (XRD), and elemental analysis. The effects of pH, contact time, concentration, and temperature were evaluated in batch adsorption tests. Cel-SiN efficiently adsorbed AMI and EY in aqueous media, with maximum adsorption capacities of 92.28 ±â€¯1.34 mg g-1 for AMI (pH = 7, time =240 min, and temperature = 318 K) and 61.0 ±â€¯0.36 mg g-1 for EY (pH = 5, time =80 min, and temperature = 298 K). The adsorption process occurs mainly via hydrogen bonding interactions for AMI and electrostatic interactions for EY.

New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.

Mesoporous silica nanoparticles (MSNs) displays interesting properties for biomedical applications such as high chemical stability, large surface area and tunable pores diameters and volumes, allowing the incorporation of large amounts of drugs, protecting them from deactivation and degradation processes acting as an excellent nanoplatform for drug delivery. However, the functional MSNs do not present the ability to transport the therapeutics without any leakage until reach the targeted cells causing side effects. On the other hand, the hydroxyls groups available on MSNs surface allows the conjugation of specific molecules which can binds to the overexpressed Enhanced Growth Factor Receptor (EGFR) in many tumors, representing a potential strategy for the cancer treatment. Beyond that, the targeting molecules conjugate onto mesoporous surface increase its cell internalization and act as gatekeepers blocking the mesopores controlling the drug release. In this context, multifunctional MSNs emerge as stimuli-responsive controlled drug delivery systems (CDDS) to overcome drawbacks as low internalization, premature release before to reach the region of interest, several side effects and low effectiveness of the current treatments. This review presents an overview of MSNs fabrication methods and its properties that affects drug delivery as well as stimuli-responsive CDDS for cancer treatment.

Luminescent Mesoporous Silica Nanohybrid Based on Drug Derivative Terbium Complex.

Mesoporous silica nanoparticles prepared by organic template-driven synthesis have been successfully explored as carriers of the drug-derivate green luminescent complex of terbium (III) with the nonsteroidal anti-inflammatory drug ketoprofen. The terbium (III) complex was synthesized by reacting ketoprofen sodium salt with terbium (III) chloride, which was further adsorbed onto the surface of mesoporous nanoparticles with a mean particle size of 47 ± 4 nm and pore size of 11 nm. The incorporation of the complex into mesoporous silica nanoparticles was tracked by the decrease in the surface area and pore size of the nanoparticles, and successfully demonstrated by substantial changes in the adsorption isotherms and thermal and vibrational spectroscopy results. The cytotoxicity assay and confocal microscopy have shown that the novel luminescent nanohybrid presents high cell viability and the characteristic terbium (III) emission can be assessed through two-photon excitation, which paves the way for bioimaging applications in nanomedicine.

Potential of amino-functionalized cellulose as an alternative sorbent intended to remove anionic dyes from aqueous solutions.

Adsorption has been explored to minimize the pollution caused by dyes. This work relates the preparation of diethylenetriamine-modified cellulose (DetaCel) by reacting phthalic anhydride-modified cellulose (PhCel) with diethylenetriamine (Deta). Materials were characterized by Elemental Analysis and results showed a degree of incorporation of 5.55 ±â€¯0.02 mmol of nitrogen per gram of modified material. The main bands observed for DetaCel by Fourier-Transform Infrared Spectroscospy (FTIR) were attributed to CN deformation (1330 cm-1) and NH stretching of amide (3400 cm-1), while Solid State Nuclear Magnetic Resonance of 13C (13C{1H}CP-MAS NMR) showed a signal at 164.6 ppm characteristic of amide group. Crystallinity index (CrI) obtained by X-Ray Diffraction (XRD) was 74.99 (Cel), 58.64 (PhCel) and 46.12% (DetaCel). Adsorbent matrices were employed to remove methyl orange (MO) and eosin (EY) dyes in aqueous medium. Data obtained experimentally from kinetic study had a better fit to the pseudo-first order, thus the adsorption process occurs in monolayer, with MO adsorption capacity by Cel and DetaCel of 2.19 and 65.45 mg g-1, respectively. For EY adsorption by Cel and DetaCel was 1.30 and 56.69 mg g-1, respectively. These results suggest that DetaCel can be used as an alternative potential for removal dyes in aqueous solution.

Retrograded starch/pectin coated gellan gum-microparticles for oral administration of insulin: A technological platform for protection against enzymatic degradation and improvement of intestinal permeability.

Gellan gum microparticles coated with colon-specific films based on retrograded starch and pectin was developed for enhancing the oral release of insulin (INS). The system developed promoted an impressive protection of INS (80%) after 120 min of incubation with trypsin and alpha-chymotrypsin, while only 3% of free INS remained intact after the same time, possibility due to the calcium chelating activity of the polymers in inhibiting the proteolytic activity. In vitro INS release in media simulating the gastrointestinal portions revealed a pH-dependent behavior, as well as the significance of the coating in lowering the release rates in relation to their counterparts. The permeability of INS on Caco-2 cells monolayers and excised rat intestine were significantly improved, mainly due to the influence of the anionic polymers on tight junctions opening, along with the excellent mucoadhesive properties of the gellan gum. All these features together contributed greatly to the hypoglycemic effect observed after the oral administration of the INS-loaded MP in diabetic rats, with reduction of up to 51% of blood glucose levels. The important findings of this work should contribute to the advances about the search of alternatives for oral administration of INS.

Direct Modification of Microcrystalline Cellulose with Ethylenediamine for use as Adsorbent for Removal Amitriptyline Drug from Environment.

Cellulose derivatives have been widely used as adsorbents for the removal of micropollutants such as drugs, dyes, and metals, due to their abundance, low cost and non-contaminating nature. In this context, several studies have been performed searching for new adsorbents (cellulose derivatives) efficient at contaminant removal from aqueous solutions. Thus, a new adsorbent was synthesized by chemical modification of cellulose with ethylenediamine in the absence of solvent and applied to the adsorption of amitriptyline (AMI) in aqueous solution. The modification reaction was confirmed by X-ray Diffraction (XRD), elemental analysis, Fourier Transform Infrared Spectroscopy (FTIR), Thermogravimetry/Differential Scanning Calorimeter (TG/DSC), solid state Nuclear Magnetic Resonance of ¹H and 13C (¹H-NMR and 13C-NMR). Moreover, the effectiveness of reaction was confirmed by computational calculations using Density Functional Theory (DFT) at level B3LYP/6-31G(d). This adsorption process was influenced by pH, time, concentration, temperature and did not show significant changes due to the ionic strength variation. Through these experiments, it was observed that the maximum adsorption capacity of AMI by CN polymer at 298 K, 300 min, and pH 7 was 87.66 ± 0.60 mg·g-1.

Resistant starch/pectin free-standing films reinforced with nanocellulose intended for colonic methotrexate release.

Although resistant starch/pectin (RS/P) films have previously displayed suitable properties for colon-specific drug delivery, nanocomposite films were developed aiming to enhance physicochemical, thermal, mechanical and barrier properties, as well as the low oral bioavailability of methotrexate (MTX). FEG-SEM micrographs of nanocomposite films showed different interaction patterns occurring among nanocellulose and RS/P. The nanofiller addition led to an increase in the thermal stability, probably due to its interaction with RS crystalline double helices. Results also displayed an improvement of the puncture strength, while barrier properties revealed a low water vapor permeability. Ex vivo bioadhesion test displayed the nanocomposites films to interact strongly with porcine gastrointestinal mucosa. In vitro drug release studies showed that the films developed enhanced the drug dissolution rates with approximately 80% of MTX release in 150min, suggesting the potential of these materials as a poor solubility drugs carrier, which constitutes an important tool for enhancing oral bioavailability.